Coherus BioSciences, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
0.9540
-0.0383 (-3.86%)
May 9, 2025, 12:56 PM - Market open
Coherus BioSciences Market Cap
Coherus BioSciences has a market cap or net worth of $110.59 million as of May 9, 2025. Its market cap has decreased by -54.99% in one year.
Market Cap
110.59M
Enterprise Value
287.69M
1-Year Change
-54.99%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since November 6, 2014, Coherus BioSciences's market cap has decreased from $404.20M to $110.59M, a decrease of -72.64%. That is a compound annual growth rate of -11.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2025 | 109.60M | -31.07% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 668.72B |
| Johnson & Johnson | 375.28B |
| UnitedHealth Group | 354.56B |
| AbbVie | 324.63B |
| Novo Nordisk | 301.56B |
| Abbott Laboratories | 233.90B |
| Novartis AG | 218.96B |
| AstraZeneca | 217.30B |